Wed, September 27, 2023
Tue, September 26, 2023
Mon, September 25, 2023
Fri, September 22, 2023
Thu, September 21, 2023
Wed, September 20, 2023

Vamil Divan Maintained (TVTX) at Strong Buy with Decreased Target to $18 on, Sep 22nd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-18-on-sep-22nd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Vamil Divan of Guggenheim, Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Decreased Target from $25 to $18 on, Sep 22nd, 2023.

Vamil has made no other calls on TVTX in the last 4 months.



There are 6 other peers that have a rating on TVTX. Out of the 6 peers that are also analyzing TVTX, 2 agree with Vamil's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Tim Lugo of "William Blair" Downgraded from Buy to Hold on, Thursday, September 21st, 2023
  • Nicole Gabreski of "Piper Sandler" Maintained at Hold with Decreased Target to $19 on, Friday, August 18th, 2023


These are the ratings of the 4 analyists that currently disagree with Vamil


  • Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $26 on, Friday, July 21st, 2023
  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $35 on, Tuesday, July 18th, 2023
  • Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $23 on, Wednesday, June 21st, 2023
  • Tyler Van Buren of "TD Cowen" Initiated at Buy and Held Target at $30 on, Monday, May 22nd, 2023

Publication Contributing Sources